Hope Is Not a Soft Concept, It’s a Strategic Imperative in Cancer InnovationNews DeskAugust 2, 20260 In medical innovation, we prioritize evidence, outcomes, and economics. Metrics such as clinical endpoints, regulatory milestones, reimbursement pathways, and market…